(a)
(b)
(c)
(d)
Figure 5:
Expression levels of angiogenic factors, by xMAP analysis (a and b) and ELISA (c and d). Statistical significance (one way Anova):
for bFGF and VEGF over-expression in sera from glioblastoma patients versus control, by both methods.